WASHINGTON -- Business-to-business e-commerce won't succeed without collaboration between manufacturers and retailers, according to a new study. initiatives, according to the study, conducted by ...

Entered into an additional clinical study collaboration and supply agreement with Gilead to evaluate IDE397, IDEAYA’s MAT2A inhibitor, in combination with Trodelvy, Gilead’s Trop-2 directed ADC, in ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. McALLEN, Texas (Border Report) — A new study ...

Collaboration between nurses and infection prevention personnel may help reduce rates of methicillin-resistant Staphylococcus aureus, according to a study published in the American Journal of ...

– Entered collaboration with Pfizer to evaluate triplet combination of STX-478 + atirmociclib + fulvestrant in frontline patients with PI3Kα-mutated HR+/HER2- metastatic breast cancer; trial ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a new research study sponsored by Tempus and ...

Advarra has integrated its electronic institutional review board (eIRB) system, known as Center for IRB Intelligence (CIRBI), with its single-sign-on-enabled software, Study Collaboration, for ...

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a precision medicine oncology company committed to the discovery and development of targeted ...

Pursuant to the clinical study collaboration and supply agreement, IDEAYA and Gilead retain the commercial rights to their respective compounds, including with respect to use as a monotherapy or ...

Entered into Clinical Study Collaboration and Supply Agreement with Gilead to evaluate IDE397, IDEAYA's MAT2A inhibitor, in combination with sacituzumab-govitecan-hziy ("Trodelvy") Gilead's Trop-2 ...